Skip to main content

Mechanisms of Reversible Injury and Neuroprotection

  • Chapter
Stroke

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 27))

  • 183 Accesses

Abstract

A key element of the emerging strategy for acute care of stroke is to protect brain tissue from damage until cerebral blood flow can be restored. To that end a number of potential neuroprotective drugs are now in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pan Y, Lo EH, Matsumoto K, et al (1995) Quantitative and dynamic MRI of neuroprotection in experimental stroke. J Neurological Sciences 131 (2):128–134

    Article  CAS  Google Scholar 

  2. Nishikawa T, Kirsch JR, Koehler RC, et al (1994) Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats. Stroke 25:2258–2264

    Article  PubMed  CAS  Google Scholar 

  3. Matsumiya N, Koehler RC, Kirsch JR, et al (1991) Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke 22:1193–1200

    Article  PubMed  CAS  Google Scholar 

  4. Nishikawa T, Kirsch JR, Koehler RC, et al (1994) Nitric oxide synthase inhibition reduces caudate injury following transient focal ischemia in cats. Stroke 25:877–885

    Article  PubMed  CAS  Google Scholar 

  5. Maruki Y, Koehler RC, Kirsch JR, et al (1995) Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia. J Cerebral Blood Flow & Metabolism 15 (1):88–96

    Article  CAS  Google Scholar 

  6. Haseldonckx M, Van Reempts J, Van de Ven M, et al (1997) Protection with lubeluzole against delayed ischemic brain damage in rats. A quantitative histopathologic study. Stroke 28 (2):428–432

    Article  PubMed  CAS  Google Scholar 

  7. De Ryck M, Keersmaekers R, Duytschaever H, et al (1996) Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats. Journal of Phar-macology & Experimental Therapeutics 279:748–758

    Google Scholar 

  8. Diener HC, Hacke W, Hennerici M, et al (1996) Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. Stroke 27:76–81

    Article  PubMed  CAS  Google Scholar 

  9. European/Australian Lubeluzole Study

    Google Scholar 

  10. North American Lubeluzole Study

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Traystman, R.J., Hennerici, M. (1998). Mechanisms of Reversible Injury and Neuroprotection. In: Steiner, T., Hacke, W., Hanley, D.F. (eds) Stroke. Update in Intensive Care and Emergency Medicine, vol 27. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60264-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60264-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64326-2

  • Online ISBN: 978-3-642-60264-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics